The landscape of mRNA therapeutics has evolved rapidly beyond COVID-19 vaccines, transitioning into a versatile platform for oncology, rare genetic diseases, autoimmune disorders, and advanced infectious disease prevention. This transformation is largely driven by mRNA's modularity and significant advancements in delivery technologies.

mRNA Engineering & Delivery Innovations Therapeutic mRNA is synthetically engineered to mimic natural eukaryotic mRNA, comprising a 5′ cap, untranslated regions (UTRs), an open reading frame (ORF), and a 3′ poly(A) tail. Nucleotide modifications, such as N1-methylpseudouridine, and optimal 5' capping (e.g., Cap 1) significantly reduce innate immune activation, enhance mRNA stability, and increase translation efficiency. Because naked mRNA is easily degraded by enzymes, Lipid Nanoparticles (LNPs) have beco ...